Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2020-06-23

FDA Approved: TERIFLUNOMIDE — Supplemental Application (Aurobindo Pharma Limited)

View source ↗

Summary

FDA approved a supplemental application for a generic teriflunomide from Aurobindo Pharma Limited, enabling its marketing for multiple sclerosis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Teriflunomide (teriflunomide)

Snippet

SUPPL AP for TERIFLUNOMIDE (TERIFLUNOMIDE)